Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
Top Cited Papers
Open Access
- 1 May 2022
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 81 (5), 523-532
- https://doi.org/10.1016/j.eururo.2021.10.035
Abstract
No abstract availableKeywords
Funding Information
- Swedish Cancer Society
This publication has 37 references indexed in Scilit:
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder TumoursEuropean Urology, 2016
- A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial CancerEuropean Urology, 2015
- Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial CarcinomaPLOS ONE, 2015
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial CarcinomaCancer Discovery, 2014
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline ChemotherapyCancer Cell, 2014
- A Molecular Taxonomy for Urothelial CarcinomaClinical Cancer Research, 2012
- Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancerLung Cancer, 2009
- A strategy for predicting the chemosensitivity of human cancers and its application to drug discoveryProceedings of the National Academy of Sciences of the United States of America, 2007
- Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis CollaborationEuropean Urology, 2005
- Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers through Genome-Wide Gene Expression ProfilingClinical Cancer Research, 2005